A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
The investigators hypothesise that long term statin treatment will improve patients' symptoms
through its anti-inflammatory effect. The beneficial effects on patient symptoms (cough,
sputum volume, bacterial load, airway function, exercise tolerance, exacerbation frequency
and health related quality of life) will be consequent on reduced neutrophilic airways
inflammation.